CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research investigates a novel persulfide donor, cysteine trisulfide, for its potential therapeutic effects on cardiovascular disease. The project aims to understand its mechanisms and evaluate its efficacy in cellular and animal models.
Cardiovascular disease (CVD) is the number one most fatal disease worldwide and despite many efforts, there is still no current treatment.
Thus, the discovery of novel therapeutics to treat CVD is critical.
Persulfides are biologically-relevant sulfur species that display much therapeutic potential in a variety of human disease, including CVD.
Importantly, persulfides are potent scavengers of many disease-associated oxidants and electrophiles, making persulfides potentially relevant in the etiol…
QUEEN MARY UNIVERSITY OF LONDON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
